menu
    • menu

    Company profile for Beyond Air

    NEW Drugs in Dev: 1
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Beyond Air, we are advancing a generator and delivery system for nitric oxide that addresses the high unmet needs of patients with certain severe lung infections and respiratory conditions. We’d love to hear from you. Beyond Air Ltd., our wholly-owned subsidiary, since June 2016. Mr. Lisi was previously Senior Vice President of Business and Corporate Development at Avadel Pharmaceuticals (AVDL) where he was instrumental i...
    At Beyond Air, we are advancing a generator and delivery system for nitric oxide that addresses the high unmet needs of patients with certain severe lung infections and respiratory conditions. We’d love to hear from you. Beyond Air Ltd., our wholly-owned subsidiary, since June 2016. Mr. Lisi was previously Senior Vice President of Business and Corporate Development at Avadel Pharmaceuticals (AVDL) where he was instrumental in restructuring the company, raising $121 million and transforming it from $100 million enterprise value to $1 billion in three years.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Beyond AirUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    825 East Gate Boulevard Suite 320 Garden City, NY 11530
    Telephone
    Telephone
    +1-516-665-8200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.beyondair.net/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/beyondair/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    XTL Update On Recent Developments
    XTL Update On Recent Developments

    29 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/29/3229091/0/en/XTL-Update-on-Recent-Developments.html

    GLOBENEWSWIRE
    29 Jan 2026
    Share Share
    Beyond Air to Attend Two Upcoming Healthcare Investor Conferences
    Beyond Air to Attend Two Upcoming Healthcare Investor Conferences

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3227075/0/en/Beyond-Air-to-Participate-in-Two-Upcoming-Healthcare-Investor-Conferences.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Beyond Air Sets Q3 Financial Results Conference Call, Webcast
    Beyond Air Sets Q3 Financial Results Conference Call, Webcast

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225973/0/en/Beyond-Air-Schedules-Third-Fiscal-Quarter-2026-Financial-Results-Conference-Call-and-Webcast.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share
    Beyond Air Announces $5M Private Placement Under Nasdaq Rules
    Beyond Air Announces $5M Private Placement Under Nasdaq Rules

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/14/3218639/0/en/Beyond-Air-Announces-5-0-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share
    XTL Bio Acquires 85% Beyond Air's Neuronos, Enters Autism Market
    XTL Bio Acquires 85% Beyond Air's Neuronos, Enters Autism Market

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217669/0/en/XTL-Biopharmaceuticals-Acquires-85-of-Beyond-Air-s-Subsidiary-NeuroNOS-Entering-the-Massive-Autism-Market-with-Nobel-Prize-Winning-Scientific-Leadership.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Beyond Air Appoints Dan Moorhead As Chief Financial Officer
    Beyond Air Appoints Dan Moorhead As Chief Financial Officer

    30 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/30/3211320/0/en/Beyond-Air-Appoints-Dan-Moorhead-as-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    30 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search